Hydroxymethylglutaryl-CoA synthase
| 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | HMGCS1 | ||||||
| Alt. symbols | HMGCS | ||||||
| NCBI gene | 3157 | ||||||
| HGNC | 5007 | ||||||
| OMIM | 142940 | ||||||
| RefSeq | NM_002130 | ||||||
| UniProt | Q01581 | ||||||
| Other data | |||||||
| EC number | 2.3.3.10 | ||||||
| Locus | Chr. 5 p14-p13 | ||||||
| |||||||
| 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | HMGCS2 | ||||||
| NCBI gene | 3158 | ||||||
| HGNC | 5008 | ||||||
| OMIM | 600234 | ||||||
| RefSeq | NM_005518 | ||||||
| UniProt | P54868 | ||||||
| Other data | |||||||
| Locus | Chr. 1 p13-p12 | ||||||
| |||||||
| Hydroxymethylglutaryl-coenzyme A synthase N terminal | |||||||||
|---|---|---|---|---|---|---|---|---|---|
staphylococcus aureus 3-hydroxy-3-methylglutaryl-coa synthase | |||||||||
| Identifiers | |||||||||
| Symbol | HMG_CoA_synt_N | ||||||||
| Pfam | PF01154 | ||||||||
| Pfam clan | CL0046 | ||||||||
| InterPro | IPR013528 | ||||||||
| PROSITE | PDOC00942 | ||||||||
| |||||||||
| Hydroxymethylglutaryl-coenzyme A synthase C terminal | |||||||||
|---|---|---|---|---|---|---|---|---|---|
staphylococcus aureus 3-hydroxy-3-methylglutaryl-coa synthase | |||||||||
| Identifiers | |||||||||
| Symbol | HMG_CoA_synt_C | ||||||||
| Pfam | PF08540 | ||||||||
| Pfam clan | CL0046 | ||||||||
| InterPro | IPR013746 | ||||||||
| PROSITE | PDOC00942 | ||||||||
| |||||||||
In biochemistry, hydroxymethylglutaryl-CoA synthase or HMG-CoA synthase EC 2.3.3.10 is an enzyme which catalyzes the reaction in which acetyl-CoA condenses with acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). This reaction comprises the second step in the mevalonate-dependent isoprenoid biosynthesis pathway. HMG-CoA is an intermediate in both cholesterol synthesis and ketogenesis. This reaction is overactivated in patients with diabetes mellitus type 1 if left untreated, due to prolonged insulin deficiency and the exhaustion of substrates for gluconeogenesis and the TCA cycle, notably oxaloacetate. This results in shunting of excess acetyl-CoA into the ketone synthesis pathway via HMG-CoA, leading to the development of diabetic ketoacidosis.
The 3 substrates of this enzyme are acetyl-CoA, H2O, and acetoacetyl-CoA, whereas its two products are (S)-3-hydroxy-3-methylglutaryl-CoA and CoA.
In humans, the protein is encoded by the HMGCS1 gene on chromosome 5.